Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety Study of MGAH22 in HER2-positive Carcinomas

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01148849
Recruitment Status : Active, not recruiting
First Posted : June 22, 2010
Last Update Posted : February 24, 2021
Sponsor:
Collaborators:
Green Cross Corporation
National Cancer Institute (NCI)
Information provided by (Responsible Party):
MacroGenics

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : December 2021
Estimated Study Completion Date : December 2021